Skip to main content

The cost of cancer: new drugs show success at a steep price

April 03, 2017

Newer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year.

Full story

Get the latest on healthcare leadership in your inbox.